OZEMRoundhill GLP-1 & Weight Lo...


$ 26.95 $ 0.35 (1.31 %)    

Tuesday, 25-Jun-2024 15:52:14 EDT
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 26.97
$ 26.90
$ 0.00 x 0
$ 0.00 x 0
$ 26.90 - $ 27.15
$ 24.51 - $ 27.15
78,270
na
na
$ -0.03
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 etfs-bet-high-on-weight-loss-drugs-but-industry-observers-question-long-term-potential

New ETFs focusing on weight-loss drugs have launched. However, industry observers caution about their long-term prospects and t...

 new-weight-loss-etf-is-essentially-a-play-on-eli-lilly-novo-nordisk

New OZEM ETF offers investors exposure to weight-loss sector through top pharmaceutical companies Eli Lilly and Novo Nordisk, w...

 south-park-took-on-crypto-ai-previously-animated-comedy-targets-weight-loss-drug-ozempic-next

Weight loss drugs get the new parody treatment in a "South Park" streaming special.

 exclusive-roundhill-investments-launches-weight-loss-etf-for-exposure-to-blockbuster-drugs-like-ozempic

Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and c...

Core News & Articles

OZEM provides exposure to the rapidly growing weight loss management market, which is expected to reach $100 billion by 2030.NE...